GCM Grosvenor Inc (GCMG)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at GCM Grosvenor Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 12.50 $ — 70% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
8 of 10 Growth gemTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 6.8% failed
- More than 10% revenue growth is expected for the coming year 14.0% passed
- Share count grows by less than 3% a year 1.5% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 41.1% passed
- Gross margin at 40% or higher and without meaningful erosion 99.2% passed
- Goodwill from acquisitions does not grow faster than revenue 3.6% passed
- Net debt below twice EBITDA 1.4 x EBITDA passed
- Operating cash flow covers the profits of the last three years 348 m passed
- Return on capital at 15% or higher, or up versus two years ago 22.3% passed
- Insiders hold at least 10% or are net buyers 2.9% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 20.0% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.86 | 0.83 – 0.90 | 573 | 2.9% | 5 |
| 12/31/2027 | 1.05 | 1.00 – 1.13 | 653 | 21.8% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.15 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.04 | 129.00 | 170 | 47.10 | 4.50 | 38 | 37 |
| 2025: Q1 | 0.00 | -78.40 | 125 | 12.10 | 0.40 | 33 | 32 |
| 2025: Q2 | 0.08 | 211.50 | 118 | 0.50 | 13.10 | 42 | 41 |
| 2025: Q3 | 0.05 | 143.70 | 133 | 8.20 | 7.90 | 80 | 78 |
| 2025: Q4 | 0.09 | 138.10 | 175 | 3.10 | 10.80 | 29 | 24 |
| 2026: Q1 | 0.03 | 994.90 | 123 | -1.40 | 4.40 | 52 | 48 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | – | 0 | 0 | 0.00 | – | 0 | 0 |
| 2017 | 377 | 73 | 74 | 1.86 | 127 | – | – |
| 2018 | 379 | 75 | 64 | 1.60 | 117 | -327 | 372 |
| 2019 | 417 | 80 | 60 | 1.50 | 96 | -315 | 373 |
| 2020 | 434 | -61 | 4 | 0.02 | 68 | 76 | 632 |
| 2021 | 539 | 126 | 21 | 0.11 | 179 | -56 | 582 |
| 2022 | 452 | 112 | 20 | 0.11 | 217 | -20 | 489 |
| 2023 | 436 | -19 | 13 | 0.07 | 92 | -28 | 505 |
| 2024 | 504 | 47 | 19 | 0.10 | 149 | -28 | 613 |
| 2025 | 550 | 148 | 45 | 0.23 | 184 | 27 | 814 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
GCM Grosvenor Inc. ist ein globaler Anbieter von Lösungen für die Verwaltung alternativer Vermögenswerte.
| Employees | 553 |
|---|---|
| Headquarters | Chicago, IL |
| Address | 900 North Michigan Avenue, 60611-6558 Chicago, United States |
| Phone | 312-506-6500 |
| Website | gcmgrosvenor.com |
| IPO Date | 18. Nov 2020 |
| ISIN | US36831E1082 |
| Stock Split | 1:1 on 11/18/2020 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Michael Jay Sacks J.D. | Board Chairman & CEO | 1963 |
| Jonathan Reisin Levin | President & Director | – |
| Frederick Emmer Pollock J.D. | Chief Investment Officer & Office of the Chairman | 1980 |
| Eric David Levin | CTO & Office of the Chairman | – |
| Stacie Driebusch Selinger | Head of Investor Relations & MD, Office of the Chairman | – |
| Burke Johnson Montgomery J.D. | General Counsel & MD | – |
| Dawna L. Daniel | Executive Director of Legal & Compliance | – |
| Kevin P. Buchheit | Head of Strategy, Corporate Development & Office of the Chairman | – |
| Cara Romaine Elckholt Fixler | MD & Chief Human Resource Officer | – |
| David Bruce Small | Managing Director of Absolute Return Strategies | 1956 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 16. Jul 2026 | Cantor Fitzgerald, L. P. | 10% Owner | Sell | 426,550 | 13.57 | 5,788,284 |
| 15. Jul 2026 | Cantor Fitzgerald, L. P. | 10% Owner | Sell | 4,000 | 14.24 | 56,960 |
| 15. Jul 2026 | Cantor Fitzgerald, L. P. | 10% Owner | Sell | 126,556 | 13.83 | 1,750,269 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.